Annotation Detail for SLC4A1
Basic Information
TopGene Symbol: | SLC4A1 ( AE1,BND3,CD233,DI,EMPB3,EPB3,FR,MGC116750,MGC116753,MGC126619,MGC126623,RTA1A,SW,WD,WD1,WR ) |
---|
Gene Full Name: | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) |
---|
Band: | 17q21.31 |
---|
Quick Links | Entrez ID:6521; OMIM: 109270; Uniprot ID:B3AT_HUMAN; ENSEMBL ID: ENSG00000004939; HGNC ID: 11027 |
---|
Relate to Another Database: |
SFARIGene;
denovo-db |
Pathway ID | Pathway Name |
---|
hsa04966 | Collecting duct acid secretion |
Pathway ID | Pathway Name |
---|
| Transmembrane transport of small molecules |
Desease ID | Desease Name |
---|
H00428 | Distal renal tubular acidosis (RTA type 1) |
| Circulatory system diseases |
| Hematologic diseases |
| Urinary system diseases |
H00230 | Hereditary spherocytosis |
H00232 | Hereditary stomatocytosis |
H00231 | Hereditary elliptocytosis |
| Kidney diseases |
Desease ID | Desease Name |
---|
1902 | Kidney failure |
2051 | Leukemia |
2053 | Colon cancer |
2152 | Renal tubular acidosis |
2204 | Hemolytic anemia |
2210 | Hemoglobinopathies |
2225 | Gram-Negative bacterial infection |
1882 | Malaria |
Desease Name |
---|
CARDIOVASCULAR |
blood pressure, arterial hypertension |
RENAL |
Familial distal renal tubular acidosis |
Desease Name |
---|
Blood group, Wright |
Renal tubular acidosis, distal, AR |
Renal tubular acidosis, distal, AD |
Ovalocytosis |
Spherocytosis, type 4 |
Blood group, Froese |
Blood group, Waldner |
Malaria, resistance to |
Blood group, Diego |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC4A1 mRNA | affects expression | 16483693
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased degradation of SLC4A1 protein | increases degradation | 15040847
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of SLC4A1 gene | increases mutagenesis | 16724327
|
C008461 |
methyl isocyanate |
methyl isocyanate binds to and results in increased degradation of SLC4A1 protein | affects binding|increases degradation | 8935787
|
C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in decreased expression of SLC4A1 mRNA | decreases expression | 17560707
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC4A1 mRNA | affects binding|decreases expression|increases activity | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D000140 |
Acidosis, Lactic |
|
methyl isocyanate |
7.18 | 8440870 |
MESH:D000141 |
Acidosis, Renal Tubular |
marker/mechanism |
|
| |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.88 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D000743 |
Anemia, Hemolytic |
marker/mechanism |
|
| |
MESH:C538565 |
Autosomal dominant distal renal tubular acidosis |
marker/mechanism |
|
| |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.19 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.59 | 15144691 16651633 16357521 16436596 18412241 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
3.93 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.50 | 17160924 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.50 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004612 |
Elliptocytosis, Hereditary |
marker/mechanism |
|
| |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.09 | 20131406 19236843 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
8.53 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
8.53 | 17162496 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.59 | 16651633 16357521 18412241 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 16221962 18467677 19176532 19772884 |
MESH:D006943 |
Hyperglycemia |
|
methyl isocyanate |
10.91 | 8440870 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
10.91 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
4.20 | 17379185 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.91 | 16377806 15890375 20007298 |
MESH:D008171 |
Lung Diseases |
|
methyl isocyanate |
5.41 | 1396463 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.63 | 17703301 16271038 16019985 6695378 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.16 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.47 | 15375218 |
MESH:D008288 |
Malaria |
marker/mechanism |
|
| |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.70 | 18041768 10838139 10767621 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.50 | 17943659 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.82 | 16707424 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.88 | 17160924 16651423 16003739 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.50 | 17160924 |
MESH:D011658 |
Pulmonary Fibrosis |
|
methyl isocyanate |
4.79 | 7708994 |
MESH:C537758 |
Renal tubular acidosis, distal, autosomal recessive |
marker/mechanism |
|
| |
OMIM:611590 |
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA |
marker/mechanism |
|
| |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.81 | 8532709 |
MESH:D013103 |
Spherocytosis, Hereditary |
marker/mechanism |
|
| |
OMIM:612653 |
SPHEROCYTOSIS, TYPE 4 |
marker/mechanism |
|
| |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.62 | 15790496 |
MESH:D014511 |
Uremia |
|
methyl isocyanate |
7.46 | 8440870 |
Pathway ID |
Pathway Name |
---|
KEGG:04966 |
Collecting duct acid secretion |
REACT:15518 |
Transmembrane transport of small molecules |
PharmGKB Accession:PA35895
Releated gene ID |
Related gene Name |
PA35895 | SLC4A1 |